Autopsy report · NCT05469490

Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors

“Lack of funding support.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Luke, Jason, MD

Sponsor type

University, hospital or other

Conditions

Advanced Solid Tumors

Interventions

Stereotactic Body Radiotherapy (SBRT); navoximod; NLG802 (indoximod Prodrug)

Participants

0

Trials that died the same way

• Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion
  “Lack of funding.” (94% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.